/ Unknown statusNot ApplicableIIT DNA Mutation Detection in Circulating Tumor DNA and Tissue by Massive Multiplex Allele Discrimination Priming System(mmADPS) for Pancreatic Cancer
Based on the cell free nucleic acid analysis information of blood samples and genetic mutation profile of EUS-FNB tissue from pancreatic cancer, the concordance between them is evaluated. And based on this information, biomarkers for diagnosis, treatment, and prognosis of pancreatic cancer are explored.
/ Unknown statusNot ApplicableIIT Practical Usability of EGFR Mutation Detection in ctDNA From Resectable NSCLC
The aim of the study is to assess the practical usability of EGFR mutation detection in ctDNA from early NSCLC.
100 Clinical Results associated with GENECAST CO LTD
0 Patents (Medical) associated with GENECAST CO LTD
100 Deals associated with GENECAST CO LTD
100 Translational Medicine associated with GENECAST CO LTD